IP Library Granted Patent US 9,035,068
Granted Patent B2
US 9,035,068 · App. 13/825,699 · Granted May 19, 2015

Phosphohistidine analogs

Inventors: Tom W. Muir (Princeton, NJ); Jung-Min Kee (Plainsboro, NJ)
Assignee: THE ROCKEFELLER UNIVERSITY
A61K47/4833C07D249/04A61K31/675C07F9/65186A61K47/48061C07F9/65182C07F9/4015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,035,068
App. No.
13/825,699
Granted
May 19, 2015
Kind
B2
Abstract

The present invention relates to the phosphohistidine analogs of the present invention which of the formula (I) and the hapten containing the residue of same. It also relates to the hapten conjugated to a carrier molecule and the isolated antibodies raised against the immunogens, said antibodies recognizing polypeptide containing a phosphorylated histidine or the phosphotriazole residue but it does not recognize an amino acid or polypeptide that is not phosphorylated or a polypeptide which is phosphorylated on amino acids other than histidine but not on histidine.

Claims (19)

1. A phosphoryltriazole of the formula:

or a salt thereof wherein

X and Y are independently —OR 9 , —NR 9 R 10 , SR 9 , COOR 9 , CONR 9 R 10 or H, an NHJ or COQ;

J is an amino protecting group;

Q is a carboxylic acid protecting group;

Z is CH, N or SiR 11 ;

R 11 is an alkyl group or H;

E and G are independently a chemical bond or a linker group selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, heterocyclic, heterocyclic alkyl, (O—CH 2 —CH 2 )n, or (CH 2 )q where one of the CH 2 groups is replaced by O,

n is 1-100;

q is 1-6;

R 9 and R 10 are independently hydrogen, alkyl, alkenyl, cycloalkyl, aryl, aryl alkyl, heterocyclic or heterocyclic alkyl;

one of R and R 1 is H and the other is

and R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are independently alkyl, alkenyl, cycloalkyl, aryl, cycloalkylalkyl, aryl alkyl, heterocyclic, heterocyclicalkyl or a protecting group.

2. The phosphoryltriazole of claim 1 having the formula:

3. The phosphoryltriazole according to claim 2 having the formula

or salt thereof wherein B is hydrogen or an amino protecting group and

is hydroxy or carboxylic acid protecting group.

4. The phosphoryltriazolylalanine according to claim 1 having the formula

or salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2013
From: MUIR, TOM W.; KEE, JUNG-MIN
To: THE ROCKEFELLER UNIVERSITY
Reel/Frame 030587/0159 →
Continuity (2)
Provisional Application 61386424 · Sep 24, 2010
Related Publication 20130260398A1 · Oct 3, 2013